Delivery Order SPE2DB22D3501-SPE2DB25FUZ93
Award Date
3/21/25
Potential Completion Date
3/24/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,885.60, is for the delivery of the ROTATEQ vaccine, a 2-milliliter dosage. The contract has an ultimate completion date of January 15, 2025. This contract is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,370.61, is for the supply of the ROTATEQ vaccine in 2-milliliter doses. It is a firm-fixed-price, non-set-aside contract with a completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ROTATEQ vaccine in 2 mL doses. The contract has a ceiling value of $2,887.24 and a completion date of March 12, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTATEQ vaccine in 2 milliliter doses. The contract has a ceiling value of $5,903.44 and a period of performance through March 12, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTATEQ vaccine in 2 ml vials. The contract has a total ceiling value of $1,009.64 and runs through August 2, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, will provide these critical vaccine supplies to support military treatment...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTATEQ vaccine in 2 mL dosages. The contract has a ceiling value of $1,663.95 and a period of performance through May 5, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ROTATEQ vaccine, a 2ml vaccine product. The contract has a firm fixed price of $3,035.85 and a period of performance through May 22, 2025. The contract is not set aside and was awarded on May 21, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,124.22, is for the supply of the ROTATEQ vaccine in 2 mL quantities. The contract is a firm fixed-price delivery order, with a completion date of June 6, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,033.24, is for the delivery of the ROTATEQ vaccine in 2 milliliter doses. It is a firm fixed price delivery order contract with a completion date of January 15, 2025. The contract was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,107,429 units of the ROTATEQ vaccine in 2 mL vials. The $2,613.32 contract has a completion date of November 16, 2022 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...